Last 12 months
Inside the activity.
5 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 3 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2016 Filed Oct 3, 2016 21:45 UTC |
Capone Mark ChristopherPresident & C.E.O.
|
Disposition to issuerCommon Stock | 9,238 | $20.58 | $190,118.04 |
DisclosureSEC source: 0001352413-16-000012 · edgardoc.xml · nonDerivative · entry 1 Capone Mark Christopher · CIK 0001352413 · President & C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,451 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 17, 2016 Filed Sep 20, 2016 12:52 UTC |
Ford AlexanderPresident, MGL
|
Disposition to issuerCommon Stock | 1,335 | $20.92 | $27,928.20 |
DisclosureSEC source: 0001644335-16-000010 · edgardoc.xml · nonDerivative · entry 1 Ford Alexander · CIK 0001644335 · President, MGL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,150 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 17, 2016 Filed Sep 20, 2016 13:03 UTC |
Wenstrup RichardChief Medical Officer
|
Disposition to issuerCommon Stock | 931 | $20.92 | $19,476.52 |
DisclosureSEC source: 0001645683-16-000010 · edgardoc.xml · nonDerivative · entry 1 Wenstrup Richard · CIK 0001645683 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,138 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 17, 2016 Filed Sep 20, 2016 13:08 UTC |
McDade Ralph LPresident Myriad RBM, Inc.
|
Disposition to issuerCommon Stock | 2,188 | $20.92 | $45,772.96 |
DisclosureSEC source: 0001594674-16-000017 · edgardoc.xml · nonDerivative · entry 1 McDade Ralph L · CIK 0001594674 · President Myriad RBM, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,532 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 17, 2016 Filed Sep 20, 2016 12:56 UTC |
King Gary A.Exec. VP International Ops
|
Disposition to issuerCommon Stock | 3,721 | $20.92 | $77,843.32 |
DisclosureSEC source: 0001495800-16-000020 · edgardoc.xml · nonDerivative · entry 1 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,499 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 17, 2016 Filed Sep 20, 2016 12:43 UTC |
LANCHBURY JERRY SChief Scientific Officer
|
Disposition to issuerCommon Stock | 4,752 | $20.92 | $99,411.84 |
DisclosureSEC source: 0001219036-16-000012 · edgardoc.xml · nonDerivative · entry 1 LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,493 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 17, 2016 Filed Sep 20, 2016 12:31 UTC |
MARSH RICHARD ME.V.P., General Counsel
|
Disposition to issuerCommon Stock | 4,606 | $20.92 | $96,357.52 |
DisclosureSEC source: 0001206386-16-000018 · edgardoc.xml · nonDerivative · entry 1 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,780 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 17, 2016 Filed Sep 20, 2016 12:16 UTC |
Capone Mark ChristopherPresident & C.E.O.
|
Disposition to issuerCommon Stock | 8,042 | $20.92 | $168,238.64 |
DisclosureSEC source: 0001352413-16-000010 · edgardoc.xml · nonDerivative · entry 1 Capone Mark Christopher · CIK 0001352413 · President & C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,689 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 17:55 UTC |
MARSH RICHARD ME.V.P., General Counsel
|
GrantCommon Stock | 45,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001206386-16-000016 · edgardoc.xml · nonDerivative · entry 1 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,386 F1 · kind: Consists of performance stock units granted pursuant to the Company?s 2010 Employee, Director and Consultant Equity Incentive Plan. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 30, 2016, 25% on September 30, 2017, 25% on September 30, 2018, and 25% on September 30, 2019. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 17:46 UTC |
Riggsbee Richard BryanChief Financial Officer
|
GrantCommon Stock | 47,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001621899-16-000004 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,273 F1 · kind: Consists of performance stock units granted pursuant to the Company?s 2010 Employee, Director and Consultant Equity Incentive Plan. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 30, 2016, 25% on September 30, 2017, 25% on September 30, 2018, and 25% on September 30, 2019. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 18:04 UTC |
Wenstrup RichardChief Medical Officer
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001645683-16-000008 · edgardoc.xml · nonDerivative · entry 1 Wenstrup Richard · CIK 0001645683 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,069 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 30, 2017, 25% on September 30, 2018, 25% on September 30, 2019, and 25% on September 30, 2020. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 18:29 UTC |
Drosos VirginiaPresident Assurex Health
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001554969-16-000003 · edgardoc.xml · nonDerivative · entry 1 Drosos Virginia · CIK 0001554969 · President Assurex Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 30, 2017, 25% on September 30, 2018, 25% on September 30, 2019, and 25% on September 30, 2020. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 18:24 UTC |
McDade Ralph LPresident Myriad RBM, Inc.
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001594674-16-000015 · edgardoc.xml · nonDerivative · entry 1 McDade Ralph L · CIK 0001594674 · President Myriad RBM, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,720 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 30, 2017, 25% on September 30, 2018, 25% on September 30, 2019, and 25% on September 30, 2020. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 18:03 UTC |
Tobin BernardPresident Crescendo BioScience
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628656-16-000006 · edgardoc.xml · nonDerivative · entry 2 Tobin Bernard · CIK 0001628656 · President Crescendo BioScience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,220 F2 · kind: Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 30, 2017, 25% on September 30, 2018, 25% on September 30, 2019, and 25% on September 30, 2020. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 18:03 UTC |
Tobin BernardPresident Crescendo BioScience
|
GrantCommon Stock | 49,608 | $0.00 | $0.00 |
DisclosureSEC source: 0001628656-16-000006 · edgardoc.xml · nonDerivative · entry 1 Tobin Bernard · CIK 0001628656 · President Crescendo BioScience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,220 F1 · kind: Consists of performance stock units granted pursuant to the Company?s 2010 Employee, Director and Consultant Equity Incentive Plan. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 30, 2016, 25% on September 30, 2017, 25% on September 30, 2018, and 25% on September 30, 2019. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 18:00 UTC |
King Gary A.Exec. VP International Ops
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001495800-16-000018 · edgardoc.xml · nonDerivative · entry 1 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,220 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 30, 2017, 25% on September 30, 2018, 25% on September 30, 2019, and 25% on September 30, 2020. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 17:59 UTC |
LANCHBURY JERRY SChief Scientific Officer
|
GrantCommon Stock | 46,508 | $0.00 | $0.00 |
DisclosureSEC source: 0001219036-16-000010 · edgardoc.xml · nonDerivative · entry 1 LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,245 F1 · kind: Consists of performance stock units granted pursuant to the Company?s 2010 Employee, Director and Consultant Equity Incentive Plan. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 30, 2016, 25% on September 30, 2017, 25% on September 30, 2018, and 25% on September 30, 2019. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 17:30 UTC |
Capone Mark ChristopherPresident & C.E.O.
|
GrantCommon Stock | 78,705 | $0.00 | $0.00 |
DisclosureSEC source: 0001352413-16-000008 · edgardoc.xml · nonDerivative · entry 1 Capone Mark Christopher · CIK 0001352413 · President & C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,731 F1 · kind: Consists of performance stock units granted pursuant to the Company?s 2010 Employee, Director and Consultant Equity Incentive Plan. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 30, 2016, 25% on September 30, 2017, 25% on September 30, 2018, and 25% on September 30, 2019. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 14:38 UTC |
HENDERSON JOHN TDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,007 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001226488-16-000004 · edgardoc.xml · derivative · entry 7 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,007 shares Expires 2016-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One third vests annually beginning on the 1st anniversary of the option date. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 14:38 UTC |
HENDERSON JOHN TDirector
|
SaleCommon Stock | 2,007 | $20.21 | $40,567.89 |
DisclosureSEC source: 0001226488-16-000004 · edgardoc.xml · nonDerivative · entry 4 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,500 Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 14:38 UTC |
HENDERSON JOHN TDirector
|
Exercise / conversionCommon Stock | 2,007 | $10.60 | $21,274.20 |
DisclosureSEC source: 0001226488-16-000004 · edgardoc.xml · nonDerivative · entry 3 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 14:38 UTC |
HENDERSON JOHN TDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 27,993 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001226488-16-000004 · edgardoc.xml · derivative · entry 6 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,007 Underlying: Common Stock · 27,993 shares Expires 2016-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One third vests annually beginning on the 1st anniversary of the option date. Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 14:38 UTC |
HENDERSON JOHN TDirector
|
SaleCommon Stock | 27,993 | $20.51 | $574,248.40 |
DisclosureSEC source: 0001226488-16-000004 · edgardoc.xml · nonDerivative · entry 2 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,500 Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 14:38 UTC |
HENDERSON JOHN TDirector
|
Exercise / conversionCommon Stock | 27,993 | $10.60 | $296,725.80 |
DisclosureSEC source: 0001226488-16-000004 · edgardoc.xml · nonDerivative · entry 1 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,493 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.